Elanco Animal Health Incorporated (NYSE: ELAN) today announced the U.S. Food and Drug Administration (FDA) has approved Zenrelia™, a safe, highly effective, and convenient once-daily oral JAK ...

U.S. Food and Drug Administration approves Zenrelia, a once-daily oral JAK inhibitor for dogs with allergic and atopic ...

Immune-complex vaccines will ensure long-term protection.

ZTS' innovative pet care products, along with efforts to expand the business, are expected to fuel significant growth in the future.

In a report released today, Glen Santangelo from Jefferies maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Stifel Nicolaus analyst Jonathan Block maintained a Buy rating on Zoetis (ZTS – Research Report) today and set a price target of $200.00. The company’s shares closed yesterday at $181.56.

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic ...

In this article, we are going to take a look at where Zoetis Inc. (NYSE:ZTS) stands against Jim Cramer’s other stock picks. In a recent episode of Mad Money, Jim Cramer views the current market ...

LOS ANGELES, CA / ACCESSWIRE / September 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ( ...

LOS ANGELES, CA / ACCESSWIRE / September 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Zoetis Inc. ( ...